Disposition kinetics of the monohydroxy metabolites of phencyclidine in the dog

J. R. Woodworth, Michael Mayersohn, S. M. Owens

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The monohydroxy metabolites of phencyclidine (PCP) have been suggested to contribute to the pharmacologic activity of PCP, and perhaps account for its prolonged action. The disposition kinetics of the monohydroxy metabolites of PCP were examined in dogs. Intravenous doses of the piperidine-hydroxylated metabolite (PCHP) and the trans- and cis-forms of the cyclohexylhydroxylated metabolite (trans-PPC and cis-PPC) were each administered to three dogs. The elimination half-life of each metabolite was short, with harmonic mean values of 1.29, 0.98 and 0.92 hr for PCHP, trans-PPC and cis-PPC, respectively. The compounds had large volumes of distribution, with average values of 6.7, 4.7 and 4.4 liters/kg for PCHP, trans-PPC and cis-PPC, respectively. Systemic clearances were high for each compound (51.9, 50.9 and 54.2 ml/min/kg for PCHP, trans-PPC and cis-PPC, respectively), but renal clearances were low (average values ranged from 2 to 8% of systemic clearance), suggesting that these metabolites undergo further metabolism. Analysis of acid-hydrolyzed serum and urine samples indicated that all three compounds were conjugated and that these conjugates were the primary metabolites. The conjugated metabolites exhibited elimination half-lives longer than the parent compounds after administration of the monohydroxy forms and after PCP dosing. The disposition of these metabolites suggest that these compounds are not produced in sufficient quantities or do they exhibit pharmacokinetic behavior which would be consistent with the prolonged effects from PCP.

Original languageEnglish (US)
Pages (from-to)900-904
Number of pages5
JournalJournal of Pharmacology and Experimental Therapeutics
Volume238
Issue number3
StatePublished - 1986

Fingerprint

Phencyclidine
Dogs
Half-Life
Pharmacokinetics
Urine
Kidney
Acids
1-(1-phenylcyclohexyl)-4-hydroxypiperidine
Serum

ASJC Scopus subject areas

  • Pharmacology

Cite this

Disposition kinetics of the monohydroxy metabolites of phencyclidine in the dog. / Woodworth, J. R.; Mayersohn, Michael; Owens, S. M.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 238, No. 3, 1986, p. 900-904.

Research output: Contribution to journalArticle

@article{679120403aaa40dd86a350c361e1c58a,
title = "Disposition kinetics of the monohydroxy metabolites of phencyclidine in the dog",
abstract = "The monohydroxy metabolites of phencyclidine (PCP) have been suggested to contribute to the pharmacologic activity of PCP, and perhaps account for its prolonged action. The disposition kinetics of the monohydroxy metabolites of PCP were examined in dogs. Intravenous doses of the piperidine-hydroxylated metabolite (PCHP) and the trans- and cis-forms of the cyclohexylhydroxylated metabolite (trans-PPC and cis-PPC) were each administered to three dogs. The elimination half-life of each metabolite was short, with harmonic mean values of 1.29, 0.98 and 0.92 hr for PCHP, trans-PPC and cis-PPC, respectively. The compounds had large volumes of distribution, with average values of 6.7, 4.7 and 4.4 liters/kg for PCHP, trans-PPC and cis-PPC, respectively. Systemic clearances were high for each compound (51.9, 50.9 and 54.2 ml/min/kg for PCHP, trans-PPC and cis-PPC, respectively), but renal clearances were low (average values ranged from 2 to 8{\%} of systemic clearance), suggesting that these metabolites undergo further metabolism. Analysis of acid-hydrolyzed serum and urine samples indicated that all three compounds were conjugated and that these conjugates were the primary metabolites. The conjugated metabolites exhibited elimination half-lives longer than the parent compounds after administration of the monohydroxy forms and after PCP dosing. The disposition of these metabolites suggest that these compounds are not produced in sufficient quantities or do they exhibit pharmacokinetic behavior which would be consistent with the prolonged effects from PCP.",
author = "Woodworth, {J. R.} and Michael Mayersohn and Owens, {S. M.}",
year = "1986",
language = "English (US)",
volume = "238",
pages = "900--904",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Disposition kinetics of the monohydroxy metabolites of phencyclidine in the dog

AU - Woodworth, J. R.

AU - Mayersohn, Michael

AU - Owens, S. M.

PY - 1986

Y1 - 1986

N2 - The monohydroxy metabolites of phencyclidine (PCP) have been suggested to contribute to the pharmacologic activity of PCP, and perhaps account for its prolonged action. The disposition kinetics of the monohydroxy metabolites of PCP were examined in dogs. Intravenous doses of the piperidine-hydroxylated metabolite (PCHP) and the trans- and cis-forms of the cyclohexylhydroxylated metabolite (trans-PPC and cis-PPC) were each administered to three dogs. The elimination half-life of each metabolite was short, with harmonic mean values of 1.29, 0.98 and 0.92 hr for PCHP, trans-PPC and cis-PPC, respectively. The compounds had large volumes of distribution, with average values of 6.7, 4.7 and 4.4 liters/kg for PCHP, trans-PPC and cis-PPC, respectively. Systemic clearances were high for each compound (51.9, 50.9 and 54.2 ml/min/kg for PCHP, trans-PPC and cis-PPC, respectively), but renal clearances were low (average values ranged from 2 to 8% of systemic clearance), suggesting that these metabolites undergo further metabolism. Analysis of acid-hydrolyzed serum and urine samples indicated that all three compounds were conjugated and that these conjugates were the primary metabolites. The conjugated metabolites exhibited elimination half-lives longer than the parent compounds after administration of the monohydroxy forms and after PCP dosing. The disposition of these metabolites suggest that these compounds are not produced in sufficient quantities or do they exhibit pharmacokinetic behavior which would be consistent with the prolonged effects from PCP.

AB - The monohydroxy metabolites of phencyclidine (PCP) have been suggested to contribute to the pharmacologic activity of PCP, and perhaps account for its prolonged action. The disposition kinetics of the monohydroxy metabolites of PCP were examined in dogs. Intravenous doses of the piperidine-hydroxylated metabolite (PCHP) and the trans- and cis-forms of the cyclohexylhydroxylated metabolite (trans-PPC and cis-PPC) were each administered to three dogs. The elimination half-life of each metabolite was short, with harmonic mean values of 1.29, 0.98 and 0.92 hr for PCHP, trans-PPC and cis-PPC, respectively. The compounds had large volumes of distribution, with average values of 6.7, 4.7 and 4.4 liters/kg for PCHP, trans-PPC and cis-PPC, respectively. Systemic clearances were high for each compound (51.9, 50.9 and 54.2 ml/min/kg for PCHP, trans-PPC and cis-PPC, respectively), but renal clearances were low (average values ranged from 2 to 8% of systemic clearance), suggesting that these metabolites undergo further metabolism. Analysis of acid-hydrolyzed serum and urine samples indicated that all three compounds were conjugated and that these conjugates were the primary metabolites. The conjugated metabolites exhibited elimination half-lives longer than the parent compounds after administration of the monohydroxy forms and after PCP dosing. The disposition of these metabolites suggest that these compounds are not produced in sufficient quantities or do they exhibit pharmacokinetic behavior which would be consistent with the prolonged effects from PCP.

UR - http://www.scopus.com/inward/record.url?scp=0022497246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022497246&partnerID=8YFLogxK

M3 - Article

C2 - 3746667

AN - SCOPUS:0022497246

VL - 238

SP - 900

EP - 904

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -